Iantrek’s CREST Registry reports 1-year outcomes for a bio-interventional glaucoma treatment, demonstrating significant IOP reduction, medication reduction, and a favorable safety profile, offering a ...

HALT, pairs Amarna’s SV40-derived gene delivery vector platform with Phenocell’s in vitro AMD disease model, which accurately ...

Researchers conducted a retrospective study to assess serum inflammatory biomarkers in patients with different subtypes of ...

Tenpoint Therapeutics and Visus Therapeutics have merged to focus on aging-related ocular conditions, with key products ...

VisiRose, a company formed in collaboration with Provectus Biopharmaceuticals and the University of Miami Miller School of ...

Confocal color imaging, green autofluorescence, and OCT are preferred for GA evaluation, each with unique benefits and ...

EXG102 and EXG202 are investigational gene therapy candidates for wet age-related macular degeneration that are in ...

Bausch + Lomb announced the acquisition of the ELIOS system, a laser-based technology that offers a new approach to treating ...

According to the partners, glaucoma research to be led by internationally renowned glaucoma surgeon Ike Ahmed, MD, FRCSC, ...

In an interview with Ophthalmology Times, Alon Kahana, MD, PhD, discusses interleukin-6 and its role in autoimmune diseases, particularly thyroid eye disease, noting that a promising alternative under ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Nona Biosciences has partnered with Kodiak Sciences to develop multi-target antibodies for ophthalmic diseases. Utilizing ...